Jenne Kyle
Insider CIK 1791857 · AKCA Chief Commercial Officer · IONS EVP, Chf GL Pdt Str Ofcr
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2026-04-16 | 2026-04-17 | 4,902 | $75.17 | $368.5K | 23,713 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2026-04-15 | 2026-04-17 | 12,226 | — | $0 | 74,402 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2026-04-15 | 2026-04-17 | 12,226 | — | $0 | 28,615 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2026-03-10 | 2026-03-11 | 4,675 | — | $0 | 14,025 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2026-03-10 | 2026-03-11 | 32,602 | — | $0 | 32,601 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2026-03-10 | 2026-03-11 | 4,675 | $34.69 | $162.2K | 16,389 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2026-03-10 | 2026-03-11 | 21,191 | $75.50 | $1.60M | 27,800 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2026-03-10 | 2026-03-11 | 16,086 | $76.30 | $1.23M | 11,714 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2026-03-10 | 2026-03-11 | 32,602 | $46.10 | $1.50M | 48,991 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2026-01-16 | 2026-01-20 | 1,823 | $75.96 | $138.5K | 16,389 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2026-01-15 | 2026-01-20 | 25,800 | — | $0 | 44,500 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2026-01-15 | 2026-01-20 | 7,013 | — | $0 | 29,664 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2026-01-15 | 2026-01-20 | 9,675 | — | $0 | 37,725 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2026-01-15 | 2026-01-20 | 7,013 | — | $0 | 18,212 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2026-01-02 | 2026-01-06 | 19,350 | — | $0 | 19,350 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | S Sale | 2025-04-16 | 2025-04-17 | 3,016 | $28.36 | $85.5K | 11,199 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2025-04-15 | 2025-04-17 | 12,226 | — | $0 | 36,677 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2025-04-15 | 2025-04-17 | 12,226 | — | $0 | 14,215 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2025-01-15 | 2025-01-17 | 18,700 | — | $0 | 18,700 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2025-01-15 | 2025-01-17 | 28,050 | — | $0 | 28,050 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2025-01-02 | 2025-01-06 | 18,700 | — | $0 | 18,700 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2024-02-26 | 2024-03-13 | 65,203 | — | $0 | 65,203 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 143,374 | $5.94 | $851.6K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 32,751 | $5.94 | $194.5K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 13,701 | $0.77 | $10.5K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 34,200 | $5.39 | $184.3K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 299 | $0.77 | $230 | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | U Tender | 2020-10-12 | 2020-10-13 | 52,012 | $18.15 | $944.0K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2020-09-22 | 2020-09-24 | 720 | $18.12 | $13.0K | 52,012 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2020-03-23 | 2020-03-25 | 779 | $11.75 | $9.2K | 52,732 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2020-03-19 | 2020-03-23 | 34,200 | — | $0 | 34,200 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2020-03-19 | 2020-03-23 | 16,800 | — | $0 | 53,511 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2019-10-21 | 2019-10-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2019-10-21 | 2019-10-23 | 25,000 | — | $0 | 36,711 | SEC↗ |